RadNet, Inc.
RDNTHealthcareNASDAQDiagnostics & Research
Scan Results
Daily timeframeRadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. At a $4.89B market cap, RadNet, Inc. ranks as a mid-cap company within healthcare. The company operates in two segments, Imaging Centers and Digital Health.
Market Cap
$4.89B
Beta
1.36
P/E (TTM)
—
P/E (Fwd)
65.93
EPS (TTM)
$-0.17
EPS (Fwd)
$0.94
ROE
1.8%
ROA
1.6%
Cash
$455.3M
Total Debt
$1.93B
Free CF
$190.5M
52W Change
8.2%
Annual Financials
Cash vs Debt
RadNet, Inc. carries $1.93B in total debt against $455.3M in cash reserves — debt is roughly 4.2x the cash position. Managing this leverage effectively will be important for long-term financial stability. The company generates $190.5M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of 1.8% points to modest capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 1.6% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $1.43B (2022) to $2.04B (2025), reflecting a 43% increase over the period.
As with any equity investment, RDNT carries market risk, sector-specific risk, and company-specific risk that investors should evaluate in the context of their own portfolios. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing RDNT.